BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved Peptides in 2026, What the FDA Review Means Olympia Pharmaceuticals RFK Jr. & claimed regenerative peptides like BPC 157 The Niche FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog